79 related articles for article (PubMed ID: 1495845)
1. [Spread in hospital units of a Pseudomonas aeruginosa phenotype producing a beta-lactamase highly inducible by clavulanic acid in vitro].
Buisson Y; Nizou JY; Talarmin A; Meyran M
Pathol Biol (Paris); 1992 May; 40(5):566-72. PubMed ID: 1495845
[TBL] [Abstract][Full Text] [Related]
2. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
[TBL] [Abstract][Full Text] [Related]
4. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Monteil H; Jehl F
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
[TBL] [Abstract][Full Text] [Related]
5. Timentin (ticarcillin/clavulanic acid): lack of antagonism in an in vitro kinetic model, against bacteria producing inducible class-1 beta-lactamase.
Slocombe B; Cooper CE; Masters PJ; Warrack JD
J Chemother; 1989 Jul; 1(4 Suppl):353-4. PubMed ID: 16312436
[No Abstract] [Full Text] [Related]
6. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
Minchella A; Molinari L; Alonso S; Bouziges N; Sotto A; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
Li C; Nicolau DP; Lister PD; Quintiliani R; Nightingale CH
J Antimicrob Chemother; 2004 Feb; 53(2):297-304. PubMed ID: 14729755
[TBL] [Abstract][Full Text] [Related]
8. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
Aubert G; Dorche G; Frere A; Raby N; Denis M
Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
[TBL] [Abstract][Full Text] [Related]
9. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
Cavallo JD; Leblanc F; Fabre R
Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
[TBL] [Abstract][Full Text] [Related]
10. Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa.
Tausk F; Stratton CW
Antimicrob Agents Chemother; 1986 Oct; 30(4):584-9. PubMed ID: 3098162
[TBL] [Abstract][Full Text] [Related]
11. beta-Lactamases of Pseudomonas aeruginosa and susceptibility against beta-lactam antibiotics.
Thabaut A; Philippon A; Meyran M
Chemioterapia; 1985 Feb; 4(1):36-42. PubMed ID: 3921265
[TBL] [Abstract][Full Text] [Related]
12. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
Campos P; Vera A; Martin-Luengo F
Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
[No Abstract] [Full Text] [Related]
13. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance].
Bert F; Briaud I; Branger C; Lambert-Zechovsky N
Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469
[TBL] [Abstract][Full Text] [Related]
16. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
17. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.
Cavallo JD; Hocquet D; Plesiat P; Fabre R; Roussel-Delvallez M;
J Antimicrob Chemother; 2007 May; 59(5):1021-4. PubMed ID: 17412726
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
20. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
Pierson CL; Friedman BA
Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
